about
Comparison of dixon and T1-weighted MR methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients.Exercise and type 2 diabetes mellitus: changes in tissue-specific fat distribution and cardiac function.Quantitative proton MR techniques for measuring fatFast multistation water/fat imaging at 3T using DREAM-based RF shimming.Evaluation of skeletal muscle DTI in patients with duchenne muscular dystrophy.In vivo magnetic resonance spectroscopy of transgenic mouse models with altered high-energy phosphoryl transfer metabolism.In vivo magnetic resonance spectroscopy of transgenic mice with altered expression of guanidinoacetate methyltransferase and creatine kinase isoenzymes.Improved signal to noise in proton spectroscopy of the human calf muscle at 7 T using localized B1 calibration.31P MR spectroscopy and computational modeling identify a direct relation between Pi content of an alkaline compartment in resting muscle and phosphocreatine resynthesis kinetics in active muscle in humans.Multi-center reproducibility of neurochemical profiles in the human brain at 7 T.Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltrationSpatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up.Proton Magnetic Resonance Spectroscopy Indicates Preserved Cerebral Biochemical Composition in Duchenne Muscular Dystrophy Patients.Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy.Proton magnetic resonance spectroscopy shows lower intramyocellular lipid accumulation in middle-aged subjects predisposed to familial longevity.Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy.Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism.Gated dynamic 31P MRS shows reduced contractile phosphocreatine breakdown in mice deficient in cytosolic creatine kinase and adenylate kinase.Is ATP elevated in patients with GAMT deficiency?Proton observed phosphorus editing (POPE) for in vivo detection of phospholipid metabolites.Elevated phosphodiester and T2 levels can be measured in the absence of fat infiltration in Duchenne muscular dystrophy patients.Time-efficient measurement of multi-phase arterial spin labeling MR signal in white matter.Decreased cerebral perfusion in Duchenne muscular dystrophy patients.Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.Improved olefinic fat suppression in skeletal muscle DTI using a magnitude-based dixon method.Validation of a pharmacological model for mitochondrial dysfunction in healthy subjects using simvastatin: A randomized placebo-controlled proof-of-pharmacology study.Temporalis muscle hypertrophy and reduced skull eccentricity in Duchenne muscular dystrophy.Non-uniform muscle fat replacement along the proximodistal axis in Duchenne muscular dystrophy.Quantitative Dixon MRI sequences to relate muscle atrophy and fatty degeneration with range of motion and muscle force in brachial plexus injury.T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patients.Dystrophin levels and clinical severity in Becker muscular dystrophy patients.Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRIIntake of 13C-4 creatine enables simultaneous assessment of creatine and phosphocreatine pools in human skeletal muscle by 13C MR spectroscopyQuantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophyMuscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophySubject tolerance of 7 T MRI examinationsQuantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy31 P magnetic resonance spectroscopy in skeletal muscle: Experts' consensus recommendationsMulti-center evaluation of stability and reproducibility of quantitative MRI measures in healthy calf muscles
P50
Q30584754-792D7816-118E-4D87-B633-F892CC284523Q30651708-5059E867-33BB-402B-9854-AD697D216917Q30677112-3E33C2A8-E176-40B1-939C-5067BA62046BQ30863061-C83A165B-1D16-4998-ACC2-121AE43963C5Q31003448-24092001-D1F9-45DC-AE81-CE191484AF40Q31097416-EDFCAFB3-776D-42A2-BE47-8BBA0ADBCF22Q31164934-178BE4DE-79FE-412B-AB33-D607B8C2B978Q33516073-8E292B12-4195-4C81-965D-FBE3998F70F3Q35010350-90407C8D-6F17-4BB1-8B81-E8E6E7303798Q35118450-3E201373-8323-4C00-9D59-8EB032692EA2Q35577423-11D8BE29-9BEC-4B4D-9488-FF1C4E7D31CCQ37478796-604C8E0B-ED38-4914-9107-5CBE1BBC6834Q38649230-6464313C-7544-45CF-BAB1-E957B8D5295EQ38922810-5D9893AD-5E92-451A-A5E0-B3D1878BD1B7Q39409381-9B89DF40-CADB-473E-AD8B-E2B498B0DD96Q39685834-0559F8CB-FDBD-4263-A934-DBC625D71FBCQ42183670-46BAE9FB-3809-4396-A9BC-0BB276787CF6Q43154401-E713545F-2D43-4C29-B2FE-E1C45B0C607BQ46155166-1DE0FA13-658D-4B7B-9A12-3E33436DD9F4Q46892255-9E85DADB-1EDD-46AE-9B6C-8E538DBAF9D8Q48099434-EEFCA23A-CEA1-4FE3-933F-FC20F5210B68Q48217628-E4447612-DD70-41FD-B3D5-E7DD22B0E902Q48297296-93F29743-3054-45C8-95E1-EE563B535902Q48403101-2BD5EF30-1CD7-469B-AC1A-FA1939C3243AQ48648613-A57A305D-D3E6-41DD-B186-5FAE24CF589DQ48687013-827BA61B-CF18-4032-ACFC-3E3D162326DFQ49886145-2E9626FD-E463-47D7-8650-425B0ED3769BQ50676428-540ED91A-D3F8-42C9-BA8A-5D550C4FFAD5Q52679809-8551B202-FAA1-4525-A79E-9ADF30DE00D3Q52940231-199D547A-F65A-48D8-B5A7-9CD599248B4CQ53555603-2A42A954-F383-4DF2-8905-63DA2A3F26C2Q54508616-5B4C8F6E-28D0-438B-898F-F4C2BC69F46CQ64236140-2B0D5382-FC8C-4251-BDC4-C4E6EB883343Q79227751-AC934AC7-4B94-4D53-8944-66FF9A0688A6Q83575813-856F35B7-F885-41B8-B59B-5F1C22274908Q85265955-1C5BDC7A-9ED3-423B-BEE1-DF491FCE673AQ85429613-524049BE-F759-4613-AADF-8ED38AEF56C5Q87419552-4F86E308-8E99-4913-BB32-4EE2C120E99CQ89617684-5E051FD6-2692-46E5-9162-4F054E84281AQ91952680-7101DECB-2907-4401-A15C-5E98426EA657
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hermien E Kan
@ast
Hermien E Kan
@en
Hermien E Kan
@es
Hermien E Kan
@nl
Hermien E Kan
@sl
type
label
Hermien E Kan
@ast
Hermien E Kan
@en
Hermien E Kan
@es
Hermien E Kan
@nl
Hermien E Kan
@sl
prefLabel
Hermien E Kan
@ast
Hermien E Kan
@en
Hermien E Kan
@es
Hermien E Kan
@nl
Hermien E Kan
@sl
P1053
L-2385-2013
P106
P31
P496
0000-0002-5772-7177